Document is current

Article History

Received: 10 September 2024

Accepted: 18 October 2024

First Online: 2 December 2024

Declarations

:

: Ricardo Correa-Rotter has provided consultancy and received fees from AbbVie, AstraZeneca, GlaxoSmithKline, and Boehringer Ingelheim; has lectured for Amgen, Janssen, AstraZeneca, and Boehringer Ingelheim; and has received research support from GlaxoSmithKline, Novo Nordisk, and AstraZeneca. Steven J. Chadban has received payment or honoraria from AstraZeneca, Bayer, and Boehringer Ingelheim for speaker fees and advisory board participation. Laura Christen, Surendra Pentakota, and Petrina Stevens are employees of AstraZeneca. Surendra Pentakota and Petrina Stevens hold stock options. Kelli Collins Damron is an employee of the National Kidney Foundation. Lweendo Hamusankwa and Marisol Robles have no conflicts of interest to disclose. Sarah Jarvis is a Chief Medical Advisor for IBEX Innovations, locum general practitioner, medical broadcaster and former clinical consultant for Patient.info. Sarah Jarvis has received payment or honoraria from AstraZeneca, Boehringer Ingelheim, Lilly, Merck, and Novartis for speaker fees and advisory board participation. Christoph Wanner has provided consultancy to AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline, and Merck.

: This article is based on author experience and previously published research, and does not contain any new studies with human participants or animals performed by any of the authors.

: Patient authors shared their experience of living with CKD, which informed the key areas of concern (Relationships and Support; Work and Finances; Awareness, Intervention and Prevention of Disease Progression), and also contributed to the planning and development of this commentary.